The science of endothelin-1 and endothelin receptor antagonists in the management of pulmonary arterial hypertension: current understanding and future studies-Reference-Cited by-同舟云学术

The science of endothelin-1 and endothelin receptor antagonists in the management of pulmonary arterial hypertension: current understanding and future studies

Published:2009-06 Issue: Volume:39 Page:38-49
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Davie N. J.,Schermuly R. T.,Weissmann N.,Grimminger F.,Ghofrani H. A.

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2362.2009.02120.x/fullpdf

Reference116 articles.

1. Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension;Mandegar;Microvasc Res,2004

2. Cellular and molecular mechanisms of pulmonary vascular remodeling;Stenmark;Annu Rev Physiol,1997

3. Hypoxia-induced pulmonary artery adventitial remodeling and neovascularization: contribution of progenitor cells;Davie;Am J Physiol Lung Cell Mol Physiol,2004

4. Pulmonary hypertension due to BMPR2 mutation: a new paradigm for tissue remodeling?;Morrell;Proc Am Thorac Soc,2006

5. Treatment of pulmonary arterial hypertension;Humbert;N Engl J Med,2004

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Knockdown of lncRNA MEG3 promotes damage of vascular endothelial cells induced by vibration;2024-06-03

2. Unleashing the Potential of Nrf2: A Novel Therapeutic Target for Pulmonary Vascular Remodeling;Antioxidants;2023-11-07

3. Metabolic remodeling in the right ventricle of rats with severe pulmonary arterial hypertension;Molecular Medicine Reports;2021-01-25

4. Organbadversuche an humanen Pulmonalgefäßen: Beurteilung der Medikamentenwirkung zur Behandlung der pulmonalarteriellen Hypertonie;Pneumologie;2021-01-20

5. Anti-annexin V autoantibodies and vascular abnormalities in systemic sclerosis: a longitudinal study;Advances in Rheumatology;2020-07-31